Timolol maleat hydrogel 0.1% - A prospective multicenter study;Timolol maleat hydrogel 0.1% - Eine prospektive multizentrische studie

Spektrum der Augenheilkunde

Volumn 15, Issue 1, 2001, Pages 9-13

  Ardjomand, N ^a   Komericki, P ^b  

^a Universitäts Augenklinik Karl Franzens Universität   (Austria)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Efficacy; Hydrogel; Intraocular pressure; Timolol; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; HYDROGEL; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; SCHIRMER TEST;

EID: 0035079394     PISSN: 09304282     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03162911     Document Type: Article

References (20)

1. Absorption of ocular timolol
2. Compliance with ocular therapy
3. Adverse effects of topical antiglaucomatous medications on the conjunctiva
4. Overview of methods to measure and enhance patient compliance
5. Compliance with topical timolol treatment
6. A double-masked, placebo-controlled evaluation of timolol in a gel vehicle
7. Efficacy of a novel hydrogel formulation in human volunteers
8. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985
9. How can the bioavailability of timolol be enhanced?
10. Propranolol as ocular hypotensive agent
11. The intraocular pressure lowering effect of timolol in gel-forming solution
12. Gelrite: A novel ion-activated in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability oftimolol
13. Patient preference, efficacy, and compliance with timolol maleate gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma
14. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study
15. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure
16. Timolol maleat in gel-forming solution: A novel formulation oftimolol maleat
17. Evaluation of efficacy and systemic side effects after topical 0.1% timolol gel and 0.5% aqueous timolol maleate
18. Compliance with medical treatment of glaucoma
19. Improving the therapeutic index of topically applied ocular drugs